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Abstract
In China, injection drug use is a major transmission route for HIV and hepatitis C virus (HCV) infection. Timely HIV and HCV
testing among drug users is vital to earlier diagnosis, linkage to care, and retention. This study aimed to examine HIV and
hepatitis C virus (HCV) testing delays at methadone clinics in Guangdong Province, China, and identify individual-level and
clinic-level factors associated with delayed testing. Data from 13,270 individuals at 45 methadone clinics in Guangdong
were abstracted from a national web-based surveillance database. A two-level binomial logit model was used to examine
the association between individual- and clinic-level factors and delayed HIV and HCV testing, defined as receiving a test
seven or more days after initial entry into the methadone system. Among 10,046 patients tested for HIV, 1882 (18.7%) had
delayed testing; among 10,404 patients tested for HCV, 1542 (14.8%) had delayed testing. Among delayed testers, the
median time to HCV testing was significantly longer than the median time to HIV testing (73 vs. 54 days, p,0.05). In the
multivariate analysis, the likelihood of delayed HIV testing was higher among individuals with high school or greater
education (adjusted odds ratio [aOR] 1.32, 95% confidence interval [CI] 1.02–1.72) and individuals enrolled at clinics with
more patients (aOR 1.41, 95% CI 1.05–1.91, for each increase in 100). The likelihood of delayed HCV testing was higher
among women (aOR 1.51, 95% CI 1.11–2.06) and employed individuals (aOR 1.21, 95% CI 1.02–1.43). Delayed testing for HIV
and HCV is common among patients at methadone clinics in Guangdong, with many patients experiencing delays of two or
more months. Structural interventions are needed to expedite testing once individuals enter the methadone maintenance
program.
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Introduction
Timely HIV testing among most-at-risk populations is vital to
earlier diagnosis, linkage to care, and retention. Although HIV
testing is currently accessible in a variety of health care settings in
many countries, delayed diagnosis continues to be a common
problem worldwide [1], [2], [3], [4], [5]. The clinical and public
health benefits of expedited HIV treatment were demonstrated in
the HIV Prevention Trials Network (HPTN) 052 trial, which
showed a large reduction in HIV transmission and death or serious
opportunistic infections in the early therapy group [6]. In contrast,
diagnostic and therapeutic delay in HIV-infected patients can lead
to increased risk of ongoing transmission [7], morbidity [8], and
mortality [9].
In China, late HIV diagnosis continues to play a substantial role
in late access to ART [10], [11]. Early diagnosis and enrollment in
care is particularly important in a setting like China, where a large
proportion of patients diagnosed HIV-positive are already
considerably immunosuppressed [10]. For these patients, earlier
identification could have a large impact in terms of opportunistic
infections and care required, with implications for the patients’
long-term morbidity and mortality. Similarly, earlier detection of
hepatitis C virus (HCV) infection can allow for earlier initiation of
therapy, which in turn can prolong survival and prevent cirrhosis
and hepatocellular carcinoma [12].
In China, where injection drug use is a major transmission
route for HIV and HCV infection affects nearly half of injection
drug users [13], national guidelines recommend routine opt-out,
provider-initiated HIV and HCV testing for all patients at
methadone clinics upon entry. Injection drug users face
numerous barriers to accessing health care services, including
stigmatization and criminalization of drug use. Methadone
clinics offer a unique opportunity to access this hard-to-reach
population and provide care. Approximately 700 methadone
clinics serve 300,000 drug users nationwide [14]. However,
retention rates in methadone maintenance programs in China
are low [14], [15], [16], with as many as a quarter of the
patients dropping out within one month of enrollment [16].
Thus, expediting HIV and HCV testing is important for
ensuring that infected patients complete CD4 cell count testing,
disease staging, and initiation of treatment while they are
actively enrolled in methadone maintenance services.
Individual-level factors, such as younger age and lower
educational status, that might influence patients’ initial willing-
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ness to undergo testing can lead to delays in HIV and HCV
testing. Additionally, clinic-level factors–staffing, intake proto-
cols, and quality of pre-test counseling–can contribute to testing
delays. Most studies of expedited HIV testing have focused on
improving individual test-seeking behavior [3], [5], neglecting
the institutional and structural factors that also contribute to
delayed HIV testing. We examine HIV and HCV testing delays
at methadone clinics in Guangdong Province, China and
identify individual-level and clinic-level factors associated with
delayed testing.
Methods
Ethics Statement
This study was approved by the Health Bureau of Guangdong
Province and the Ethics Review Committee at Sun Yat-sen
University. Written informed consent was provided by clinical
directors who answered the questionnaire. All patients gave their
written consent for their information to be stored in the national
web-based administrative database and allowed to use for
research.
National Web-based Disease Surveillance Database of the
Methadone Maintenance Program
A national unified web-based HIV/AIDS information system
has been established by the Chinese Centers for Disease Control
and Prevention (CDC). Details of this system have been described
elsewhere [17]. Methadone maintenance treatment is one of its
eight core subsystems, and the only subsystem conducting opt-out,
provider-initiated routine testing among drug users. Clinic clients
include individuals who self-refer and those who are enrolled as
part of a post-incarceration rehabilitation plan.
According to national guidelines, providers at methadone clinics
routinely conduct HIV and HCV testing when clients register at
methadone clinics and enter results into the web-based manage-
ment database [18]. In addition, individual socio-demographic
characteristics, drug use behavior, and daily methadone dosage
are also entered into the database.
HIV and HCV Treatment
Individuals who test positive for HIV or HCV at methadone
clinics are referred by clinic staff to outside health care facilities for
further evaluation and treatment. HIV- and HCV-infected
patients are treated according to national guidelines [19], [20].
HIV patients undergo clinical and immunological staging, and
those with CD4 cell counts #3506106/L or AIDS-defining
illnesses are initiated on standardized first-line treatment regimens
that typically consist of three antiretroviral drugs [19]. HCV
patients are classified as having chronic or acute HCV infection
based on clinical and laboratory examinations and initiated on
therapy if indicated [20].
Setting
Of the people living with HIV in China who were infected
through injecting drug use, 84.2% live in six of the country’s 33
provinces/autonomous regions, including Guangdong Province
[21]. A systematic review estimated that the prevalence of HIV
and HCV among drug users in Guangdong was 2.44% and 44.6%
respectively [13]. At the time of this study, 49 methadone
maintenance clinics were established in Guangdong, covering 18
of the 23 cities in the province. This cross-sectional study was
conducted in all methadone clinics in Guangdong.
Measures
Our primary outcome was delayed testing, a dichotomous
outcome defined as receiving an HIV or HCV test seven or more
days after initial entry into the methadone system, which was
based on the date the blood sample was collected. This cutoff was
chosen because according to national guidelines seven days is the
threshold for considering someone a drop-out from the methadone
maintenance program [18]. Additionally, high rates of early
attrition from the methadone program have been observed in
Guangdong, with 24.1% of enrolled patients dropping out by the
end of the first month [16]. Early testing is necessary to ensure that
these high-risk patients are tested before they become lost to
follow-up. Thus, we used a strict definition for timely HIV and
HCV testing in methadone clinics in China.
Individual-level socio-demographic and clinical characteristics
included in the analysis were sex, age (,29 years old, 30–39 years
old,.40 years old), marital status (married, unmarried), education
completed (none/primary school, middle school, high school and
above), employment status (employed, unemployed), and drug
injecting experience (injecting, non-injecting), HIV infection status
(infected, non-infected), HCV infection status (infected, non-
infected), and years of heroin use (#5, 5 to 10, .10). Clinic-level
factors included were economic region (Pearl River Delta, non-
Pearl River Delta), administrative level (town/village level, city
level), affiliated institution (CDC, non-CDC), number of nurses
and physicians employed (2–4, 5–7, 8–10), number of clients
(,200, 200–399, $400), integration of voluntary HIV counseling
services (yes, no), clinic finances (for-profit, non-profit), and
distance between the clinic and most clients’ residences (#5
kilometers, .5 kilometers).
Data Collection
Data were collected during November and December 2008. All
individual characteristics were obtained from the web-based
management system. Clinical staff downloaded the data and
removed all identifying information. Clinic characteristics were
obtained through a self-administered questionnaire completed by
the director of each methadone clinic.
Data Analysis
Four clinics were opened less than one month prior to the study
and were not included in the analysis. A total of 13,442 individuals
were registered in the remaining 45 methadone clinics in
Guangdong Province at the time of study. 172 (1.28%) individuals
were excluded from the analysis because they had three or more
individual-level variables missing from their dataset.
First, we calculated the percentage of patients who had not yet
been tested for HIV and HCV at 3 days, 5 days, 7 days, 15 days,
and 1 month, among individuals who eventually underwent
testing, and examined the time trend. Second, we examined the
univariate associations between individual-level and clinic-level
characteristics and delayed HIV and HCV testing. Group
comparisons were examined with chi-square tests at the individual
level and with nonparametric Kruskal-Wallis tests at the clinic
level.
We observed clustering of observations at the clinic level and
decided to use multilevel modeling in order to examine the
interactions between individual- and clinic-level factors. A two-
level binomial logit model was used to estimate the effect of
individual- and clinic-level factors on delayed HIV and HCV
testing. The form and interpretation of the model are described
elsewhere [22]. In a sensitivity analysis, we re-estimated the
multilevel model using 5 days and 10 days as the cutoff for delayed
testing. The multilevel analysis was conducted using MLwiN
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Version 2.02 (Center for Multilevel Modelling, University of
Bristol, Bristol, UK), and all other analyses were conducted using
SAS Version 9.1 (SAS Institute Inc, Cary, NC, USA). Reported p-
values were two-sided, and a p-value below 0.05 was considered
significant.
Results
Data from 13,270 individuals at 45 clinics were analyzed. The
majority of individuals were male (93.9%) and heroin users
(99.6%), and 82.6% were between 20 and 40 years old. Most
individuals had completed nine years or less of school and were
unemployed at the time of the survey (Table 1).
Among the 13,270 individuals analyzed, 10,046 (75.7%) had an
HIV test and 10,404 (78.4%) underwent HCV testing. Among
those who ultimately were tested, 1882 (18.7%) had delayed HIV
testing and 1542 (14.8%) had delayed HCV testing. Among
delayed testers, the median time to HIV testing was 54 days
(range, 8–731) and the median time to HCV testing was 73 days
(range, 8–997). More individuals had delayed HIV test uptake
compared to HCV test uptake (p,0.05, see Figure S1). After one
month, 77.4% and 66.1% of the delayed HIV and HCV testers,
respectively, had still not received testing.
The majority of methadone clinics had HIV and HCV testing
delays that affected less than 10% of the clients who ultimately
were tested (Figure 1). At a small number of clinics, however, more
than 40% of clients tested experienced HIV or HCV testing
delays. In most cases, the clinics with a high percentage of delayed
HIV testing were not the same ones with a high percentage of
delayed HCV testing.
In the univariate analysis, several individual-level factors were
associated with delayed HIV testing, but no clinic-level factors
were found to be significant (see Table S1). These individual-level
factors were younger age, unmarried, high school level or above
education, non-injecting drug use, HIV-negative serostatus, and
years of heroin use. The final two-level model predicting delayed
HIV testing included one individual-level factor (higher education)
and one clinic-level factor (larger number of clients enrolled)
(Table 2). Compared with individuals who received no education
or only finished primary school, individuals who finished high
school or above were more likely to have delayed HIV testing
(adjusted odds ratio [aOR] 1.32, 95% confidence interval [CI]
1.02–1.72). Enrollment at methadone clinics with a larger number
of patients was also associated with increased likelihood of delayed
HIV testing (aOR 1.41, 95% CI 1.05–1.91).
Table 1. Individual-level characteristics of individuals at methadone clinics in Guangdong Province (N = 13,270).
Characteristic N (%) total individuals N (%) individuals tested for HIV N (%) individuals tested for HCV
Overall 13270 (100) 10046 (100) 10404 (100)
Sex
Male 12463 (93.9) 9400 (93.6) 9753 (93.7)
Female 807 (6.1) 646 (6.4) 651 (6.3)
Age (years)
,20 36 (0.3) 25 (0.2) 25 (0.2)
20–29 3242 (24.4) 2346 (23.4) 2411 (23.2)
30–39 7725 (58.2) 5907 (58.5) 6148 (59.1)
40–49 2080 (15.7) 1621 (16.1) 1664 (16.0)
50–59 177 (1.3) 140 (1.4) 149 (1.4)
.59 10 (0.1) 7 (0.1) 7 (0.1)
Marital status
Married 6446 (48.6) 4911 (48.9) 5079 (48.8)
Unmarried 6824 (51.4) 5135 (51.1) 5325 (51.2)
Education
None/primary school 2760 (20.8) 1695 (16.9) 2158 (20.7)
Middle school 8325 (62.7) 6292 (62.6) 6517 (62.6)
High school and above 2185 (16.5) 2059 (20.5) 1729 (16.6)
Employment status
Employed 4926 (37.1) 3752 (37.3) 3650 (35.1)
Unemployed 8344 (62.9) 6294 (62.7) 6754 (64.9)
Ever injected drugs
Yes 11011 (83.0) 8348 (83.1) 8663 (83.3)
No 2259 (17.0) 1698 (16.9) 1741 (16.7)
Years of heroin use
#5 2642 (19.9) 1876 (18.7) 1910 (18.4)
5 to 10 3578 (27.0) 2694 (26.8) 2794 (26.8)
.10 7050 (53.1) 5476 (54.5) 5700 (54.8)
doi:10.1371/journal.pone.0066787.t001
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The factors associated with delayed HCV testing differed from
those associated with delayed HIV testing. Significant factors in
the univariate analysis included younger age, employment, and
non-injecting drug use. The final two-level model predicting
delayed HCV testing included sex and employment status
(Table 3). Women were more likely to have delayed HCV
compared to men (aOR 1.51, 95% CI 1.11–2.06), and employed
individuals were more likely than unemployed individuals to have
delayed HCV testing rate (aOR 1.21, 95% CI 1.02–1.43). No
clinic-level factor was significantly associated delayed HCV testing
in the multivariate analysis.
In the sensitivity analysis, the multivariate model for delayed
HIV testing did not change when the threshold for delayed testing
was increased from 7 to 10 days. However, education dropped out
of the multivariate model when the cutoff was reduced to 5 days.
In all three multivariate models, the relationship between clinic
volume and delayed HIV testing remained significant (see Table
S2). For HCV, changing the threshold to 5 days resulted in gender
dropping out of the multivariate model. When the cutoff was
increased to 10 days, the significance of the gender and
employment variables was reduced but the p-value remained less
than 0.1 (see Table S3).
Discussion
Effective systems of HIV and HCV care require prompt testing,
linkage to care, and retention. This study in Guangdong Province,
China revealed that delays in HIV and HCV testing are common
at methadone clinics and often persist for months. A total of 18.7%
and 14.8% of HIV and HCV testers, respectively, were delayed in
receiving tests, despite being enrolled in the methadone clinic
system. Among delayed testers, the median delay to testing was 54
days for HIV and 73 days for HCV.
Although the importance of preventing delayed HIV and HCV
testing has been recognized, studies of testing delays often focus on
individual patient characteristics associated with late testing and
neglect the important role of institutional and systems issues.
Structural factors associated with delays in time to testing once
individual patients have accessed facilities offering HIV testing
have been understudied and underappreciated. Additionally,
delays in HCV testing among high-risk groups like injection drug
users have been understudied compared to delayed HIV diagnosis.
Methadone clinics provide a unique opportunity to explore how to
optimize these systems in order to expedite HIV and HCV testing
for drug users. To our knowledge, this is the first study of structural
factors associated with delayed HIV and HCV testing in
methadone clinics.
Existing definitions of delayed testing used in previous studies
have a number of limitations. Studies of HIV testing delays
commonly examine the outcome of delayed diagnosis, which is
defined according to CD4 count at the time of diagnosis [1], [2],
[3], [4], [23]. For HCV, delayed diagnosis has been defined as the
time from the estimated date of infection (date of initiation of
injection drug use) to the diagnosis date [24]. These definitions do
not distinguish between patient delays in accessing sites where
testing is available and delays that occur once patients have
presented for care at these sites. Other studies have reported the
occurrence of ‘‘missed opportunities,’’ defined as documented
clinical encounters when patients with clinical syndromes associ-
ated with HIV or patients belonging to high-risk groups did not
Figure 1. Distribution of delayed HIV and HCV testing rates at methadone clinics in Guangdong, China.
doi:10.1371/journal.pone.0066787.g001
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undergo testing [25], [26], [27]. Two previous studies have
reported the median time to HIV testing following patients’ initial
encounter with the health facility [25], [28]. However, there is no
established threshold for measuring delayed testing. Moreover,
these studies were undertaken among outpatients at general
hospitals and clinics, not in methadone clinic settings where
patients are evaluated on a daily basis.
Given the limitations of the existing literature, we used an
operational definition of seven or more days from enrollment to
testing to define delayed testing. We based our definition on the
number of days since enrollment because we sought to examine
the institutional issues that affect time to testing after patients’
enrollment in the methadone maintenance program. We chose
our cutoff for delayed testing with the understanding that
methadone clinics differ from other health care settings in two
key ways–the patients are evaluated on a daily basis, and they are
at high-risk for HIV and HCV infection. Given the high rates of
early attrition documented at methadone clinics in Guangdong
[16], we used a strict definition for timely testing (,7 days) in
methadone clinics in China. The testing delays documented in this
study demonstrate that there is room for improvement within the
medical system to achieve timely HIV and HCV testing among
drug users. More research is needed to better understand how to
decrease time to testing within medical infrastructures.
We found that the median delay to HCV testing was longer
than the median delay to HIV testing by almost three weeks.
Previous studies in Canada and Europe have identified poor
perception of the risk of HCV infection and the harm caused by
HCV as the main reason for delayed or missed HCV testing or
failure to seek treatment [29], [30]. Inadequate education about
Table 2. Multivariate analysis of factors associated with delayed HIV testing at methadone clinics (N = 10,046).
Characteristic
N (%) patients with delayed HIV
testing
Adjusted odds ratio (95%
confidence interval) p-value
Overall 1882 (18.7) NA
Sex
Male 1750 (18.6) – –
Female 132 (20.4) – –
Age
#29 years old 526 (22.2) – –
30–39 years old 1081 (18.3) – –
$40 years old 275 (15.6) – –
Marital status
Married 884 (17.2) – –
Unmarried 998 (20.3) – –
Education
None/primary school 382 (18.6) 1.00
Middle school 1147 (18.2) 1.17 (0.96–1.44) 0.122
High school and above 353 (20.8) 1.32 (1.02–1.72) 0.036
Employment status
Unemployed 1200 (19.1) – –
Employed 682 (18.2) – –
Ever injected drugs
Yes 1474 (17.7) – –
No 408 (24.0) – –
HIV
Infected 64 (10.7) – –
Non-infected 1818 (19.2) – –
HCV*
Infected 1219 (19.4) – –
Non-infected 560 (19.3) – –
Years of heroin use
#5 501 (26.7) – –
5 to 10 561 (20.8) – –
.10 820 (15.0) – –
Total number of clients (for each increase in 100) ** - 1.41 (1.05–1.91) 0.024
*103 individuals who had delayed HIV testing did not undergo HCV testing.
**Total number of clients is the only clinic-level variable associated with delayed HIV testing in the multivariate analysis. Other non-significant clinic-level variables are
not presented in the table. The complete results of the univariate analysis of clinic-level variables are presented in Table S1.
doi:10.1371/journal.pone.0066787.t002
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HCV among drug users in China may result in poor recognition of
the importance of HCV testing and longer testing delays
compared to HIV [31]. Perceptions of lower HCV risk among
women may also account for relationship between female gender
and delayed HCV testing found in our study.
Our study found that methadone clinics seeing a greater
number of patients had more frequent HIV test delay. Methadone
clinic staff shortage is a national problem in China and may partly
explain this relationship [32]. Health care providers in a typical
methadone clinic in China experience a heavy workload, a
problem that has also been reported in the U.S [33]. Often two or
three clinicians are managing care for more than 100 patients,
including writing prescriptions, providing counseling and health
education, tracking patients lost to follow-up, and preparing
reports [32]. The relationship between number of clients and
delayed testing was not observed for HCV. We hypothesize that
this may be because HIV counseling may require more staff time
in order to be effective; since HIV is both more stigmatized and
less prevalent compared to HCV, more intensive counseling may
be needed to overcome individuals’ resistance to testing at entry to
the methadone maintenance program.
A limitation of this study is that the methadone clinics in
Guangdong Province may differ from others in China in terms of
the type of testing technology used and existing relationships with
local hospitals to expedite routine screening. However, there were
no HIV or HCV point-of-care tests available in China at the time
of this study. Moreover, the characteristics of the study population
were comparable with those reported at methadone clinics in
other parts of China [15]. Another limitation is that we cannot
evaluate the clinical impact of delayed HIV or HCV testing.
Individuals who test positive HIV and HCV at methadone clinics
are referred to outside health care facilities for further evaluation
Table 3. Multivariate analysis of factors associated with delayed HCV testing at methadone clinics (N= 10,404).
Characteristic
N (%) patients with
delayed HCV testing
Adjusted odds ratio (95% confidence
interval) p-value
Overall 1542 (14.8) NA
Sex
Male 1437 (14.7) 1.00
Female 105 (16.1) 1.51 (1.11–2.06) 0.013
Age
#29 years old 403 (16.5) – –
30–39 years old 922 (15.0) – –
$40 years old 217 (11.9) – –
Marital status
Married 764 (14.4) – –
Unmarried 778 (15.3) – –
Education
None/primary school 308 (14.3) – –
Middle school 985 (15.1) – –
High school and above 249 (14.4) – –
Employment status
Unemployed 933 (13.8) 1.00
Employed 609 (16.7) 1.21 (1.02–1.43) 0.032
Ever injected drugs
Yes 1236 (14.3) – –
No 306 (17.6) – –
HIV*
Infected 75 (16.3) – –
Non-infected 1271 (14.6) – –
HCV
Infected 1061 (14.9) – –
Non-infected 481 (14.6) – –
Years of heroin use
#5 289 (15.1) – –
5 to 10 449 (16.1) – –
.10 804 (14.1) – –
*196 individuals who had delayed HCV testing did not undergo HIV testing.
Note: Only individual-level variables are included in this table. None of the clinical-level variables were associated with delayed HCV testing in the final multilevel model.
The complete results of the univariate analysis of clinic-level variables are presented in Table S1.
doi:10.1371/journal.pone.0066787.t003
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and HIV and HCV treatment. Their treatment data, including
timing of treatment initiation and CD4 counts, are recorded in a
separate administrative system maintained by the local CDC,
which was not accessible for the current study. Finally, patients in
the methadone program not only differ in the characteristics we
examined in this study, but also in their dependence level and
mental health. We did not include these factors because the
methadone maintenance program system does not routinely
collect information about mental health and dependence level,
but these factors may affect time to testing.
A strength of this study is that we included data from nearly all
of the 49 methadone clinics in Guangdong Province. Only four
clinics that opened less than one month prior to the study were not
included in the analysis. Another major strength of our study is
that it examines salient clinic-level factors that could be modified
to improve routine, prompt HIV and HCV testing in methadone
clinics. Our results suggest that methadone clinics that serve a
large number of patients may require capacity strengthening in
order to manage their patient load and prevent HIV testing delays.
Other clinic-level variables that we examined were not signifi-
cantly associated with testing delays in the multivariate model.
However, examination of the percentage of delayed testing at the
clinic level revealed that there is a small subset of methadone
clinics where the percentage of clients who experience delayed
HIV or HCV testing is higher than average. Clinic-level variables
that we did not examine–such as measures of staff buy-in, staff
training, or clinic resources–may account for this clinic-level
variation. Further research is needed to understand why these
clinics perform poorly on timeliness of HIV and HCV testing.
Although current national guidelines recommend routine opt-
out, provider-initiated HIV and HCV testing for all patients at
methadone clinics upon entry, testing procedures may need to be
further integrated into the intake protocols of methadone clinics in
order to ensure implementation of prompt testing. For example,
the intake protocol could require that providers offer HIV and
HCV testing routinely at multiple specified times during the first
week after entry to the methadone maintenance program. Such
redundancy early in the process could help to ensure that initial
patient refusal or individual providers’ failure to offer testing at
intake not result in prolonged testing delays.
Expediting HIV and HCV testing among drug users in China is
particularly important because they are a high-risk and hard-to-
reach population [34]. Methadone clinics are a key point of
contact between drug users and the Chinese health care system.
The cascade of services that must be completed for optimal care of
HIV or HCV infection includes initial screening, testing confir-
mation, linkage to care, disease staging, initiation of treatment,
and retention in care [35]. The existing infrastructure of
methadone clinics could be used to enhance care for drug users
infected with HIV or HCV if these services could be further
streamlined. Methadone clinics in China face a high rate of early
attrition [16]. Thus, prompt HIV and HCV testing after intake is
important for ensuring patients complete the full cascade of HIV
and HCV care services while still enrolled in the methadone
maintenance program.
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